Cargando…
Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation
CRISPR/Cas9 protein fused to transactivation domains can be used to control gene expression in human cells. In this study, we demonstrate that a dCas9 fusion with repeats of VP16 activator domains can efficiently activate human genes involved in pluripotency in various cell types. This activator in...
Autores principales: | Balboa, Diego, Weltner, Jere, Eurola, Solja, Trokovic, Ras, Wartiovaara, Kirmo, Otonkoski, Timo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618656/ https://www.ncbi.nlm.nih.gov/pubmed/26352799 http://dx.doi.org/10.1016/j.stemcr.2015.08.001 |
Ejemplares similares
-
Simultaneous high-efficiency base editing and reprogramming of patient fibroblasts
por: Jalil, Sami, et al.
Publicado: (2021) -
Human pluripotent reprogramming with CRISPR activators
por: Weltner, Jere, et al.
Publicado: (2018) -
Kaposi’s Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter
por: Elbasani, Endrit, et al.
Publicado: (2020) -
Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes
por: Balboa, Diego, et al.
Publicado: (2018) -
CRISPR activation enables high-fidelity reprogramming into human pluripotent stem cells
por: Sokka, Joonas, et al.
Publicado: (2022)